Keros Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.194; its P/E ratio is -11.41; Keros Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-1.33. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 8.00K	-	-	-	$ 0.00
Gross Profit	$ 8.00K	-	-	-	-
EBIT	$ -39.44M	$ -37.51M	$ -35.80M	$ -29.72M	$ -23.51M
EBITDA	$ -38.89M	$ -36.96M	$ -35.12M	$ -29.27M	$ -23.38M
Net Income Common Stockholders	$ -39.44M	$ -75.01M	$ -71.61M	$ -59.42M	$ -23.51M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 287.90M	$ 322.00M	$ 351.40M	$ 279.00M	$ 239.43M
Total Assets	$ 326.25M	$ 356.28M	$ 384.44M	$ 306.71M	$ 252.55M
Total Debt	$ 14.31M	$ 13.95M	$ 13.99M	$ 13.27M	$ 455.00K
Net Debt	$ -273.58M	$ -308.05M	$ -337.41M	$ -265.73M	$ -238.97M
Total Liabilities	$ 30.41M	$ 30.05M	$ 29.45M	$ 306.78M	$ 11.53M
Stockholders Equity	$ 295.84M	$ 326.26M	$ 354.98M	$ 277.42M	$ 241.03M
Cash Flow	-
Free Cash Flow	$ -34.53M	$ -31.14M	$ -35.30M	$ -21.79M	$ -24.78M
Operating Cash Flow	$ -33.98M	$ -30.83M	$ -34.23M	$ -21.44M	$ -24.60M
Investing Cash Flow	$ -550.00K	$ -311.00K	$ -1.06M	$ -351.00K	$ -176.00K
Financing Cash Flow	$ 284.00K	$ 1.74M	$ 107.68M	$ -58.08M	$ 48.58M

Currency in USD

Keros Therapeutics Earnings and Revenue History

Income Statement >

Keros Therapeutics Debt to Assets

Balance Sheet >

Keros Therapeutics Cash Flow

Cash Flow >

Keros Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing